Preferred Name |
Clavulanic Acid |
|
Synonyms |
|
|
Definitions |
A semisynthetic beta-lactamase inhibitor isolated from Streptomyces. Clavulanic acid contains a beta-lactam ring and binds strongly to beta-lactamase at or near its active site, thereby hindering enzymatic activity. This protects other beta-lactam antibiotics from beta-lactamase catalysis, thereby enhancing their antibacterial effects. This agent is used in conjunction with beta-lactamase susceptible antibiotics, such as penicillins and cephalosporins, to treat infections caused by beta-lactamase producing organisms. |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C61681 |
|
CAS_Registry |
58001-44-8 |
|
CHEBI_ID |
CHEBI:48947 |
|
Chemical_Formula |
C8H9NO5 |
|
code |
C61681 |
|
Contributing_Source |
CTRP FDA |
|
definition |
A semisynthetic beta-lactamase inhibitor isolated from Streptomyces. Clavulanic acid contains a beta-lactam ring and binds strongly to beta-lactamase at or near its active site, thereby hindering enzymatic activity. This protects other beta-lactam antibiotics from beta-lactamase catalysis, thereby enhancing their antibacterial effects. This agent is used in conjunction with beta-lactamase susceptible antibiotics, such as penicillins and cephalosporins, to treat infections caused by beta-lactamase producing organisms. |
|
Display_Name |
Clavulanic Acid |
|
FDA_UNII_Code |
23521W1S24 |
|
Has_Salt_Form | ||
in_subset |
http://purl.obolibrary.org/obo/NCIT_C63923 |
|
label |
Clavulanic Acid |
|
Legacy Concept Name |
Clavulanic_Acid |
|
Preferred_Name |
Clavulanic Acid |
|
prefixIRI |
NCIT:C61681 |
|
prefLabel |
Clavulanic Acid |
|
Semantic_Type |
Pharmacologic Substance |
|
UMLS_CUI |
C0055860 |
|
subClassOf |